264 related articles for article (PubMed ID: 36028154)
1. Nanoparticles: Attractive tools to treat colorectal cancer.
Younis NK; Roumieh R; Bassil EP; Ghoubaira JA; Kobeissy F; Eid AH
Semin Cancer Biol; 2022 Nov; 86(Pt 2):1-13. PubMed ID: 36028154
[TBL] [Abstract][Full Text] [Related]
2. Theranostics Nanomedicine Applications for Colorectal Cancer and Metastasis: Recent Advances.
Kasi PB; Mallela VR; Ambrozkiewicz F; Trailin A; Liška V; Hemminki K
Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175627
[TBL] [Abstract][Full Text] [Related]
3. A shift in focus towards precision oncology, driven by revolutionary nanodiagnostics; revealing mysterious pathways in colorectal carcinogenesis.
Sharma S; Bhattacharya S; Joshi K; Singh S
J Cancer Res Clin Oncol; 2023 Nov; 149(17):16157-16177. PubMed ID: 37650995
[TBL] [Abstract][Full Text] [Related]
4. Engineered liposomes mediated approach for targeted colorectal cancer drug Delivery: A review.
Shazleen Ibrahim I; Starlin Chellathurai M; Mahmood S; Hakim Azmi A; Harun N; Ulul Ilmie Ahmad Nazri M; Muzamir Mahat M; Mohamed Sofian Z
Int J Pharm; 2024 Feb; 651():123735. PubMed ID: 38142874
[TBL] [Abstract][Full Text] [Related]
5. Emergence of nanomedicine as cancer targeted magic bullets: recent development and need to address the toxicity apprehension.
Rahman M; Ahmad MZ; Kazmi I; Akhter S; Afzal M; Gupta G; Sinha VR
Curr Drug Discov Technol; 2012 Dec; 9(4):319-29. PubMed ID: 22725687
[TBL] [Abstract][Full Text] [Related]
6. Inorganic Nanoparticles for Cancer Therapy: A Transition from Lab to Clinic.
Bayda S; Hadla M; Palazzolo S; Riello P; Corona G; Toffoli G; Rizzolio F
Curr Med Chem; 2018; 25(34):4269-4303. PubMed ID: 29284391
[TBL] [Abstract][Full Text] [Related]
7. The Clinical Translation of Organic Nanomaterials for Cancer Therapy: A Focus on Polymeric Nanoparticles, Micelles, Liposomes and Exosomes.
Palazzolo S; Bayda S; Hadla M; Caligiuri I; Corona G; Toffoli G; Rizzolio F
Curr Med Chem; 2018; 25(34):4224-4268. PubMed ID: 28875844
[TBL] [Abstract][Full Text] [Related]
8. Diatom-Based Nanomedicine for Colorectal Cancer Treatment: New Approaches for Old Challenges.
Tramontano C; De Stefano L; Rea I
Mar Drugs; 2023 Apr; 21(5):. PubMed ID: 37233460
[TBL] [Abstract][Full Text] [Related]
9. Liposome technologies towards colorectal cancer therapeutics.
Sang R; Stratton B; Engel A; Deng W
Acta Biomater; 2021 Jun; 127():24-40. PubMed ID: 33812076
[TBL] [Abstract][Full Text] [Related]
10. Engineered nanomedicines for augmenting the efficacy of colorectal cancer immunotherapy.
Abdelgalil RM; Elmorshedy YM; Elkhodairy KA; Teleb M; Bekhit AA; Khattab SN; Elzoghby AO
Nanomedicine (Lond); 2022 Sep; 17(22):1721-1745. PubMed ID: 36621872
[TBL] [Abstract][Full Text] [Related]
11. Research advances in nanomedicine applied to the systemic treatment of colorectal cancer.
Yin L; Li H; Shi L; Chen K; Pan H; Han W
Int J Cancer; 2023 Mar; 152(5):807-821. PubMed ID: 35984398
[TBL] [Abstract][Full Text] [Related]
12. Last Advances in Nanocarriers-Based Drug Delivery Systems for Colorectal Cancer.
Rama AR; Jimenez-Lopez J; Cabeza L; Jimenez-Luna C; Leiva MC; Perazzoli G; Hernandez R; Zafra I; Ortiz R; Melguizo C; Prados J
Curr Drug Deliv; 2016; 13(6):830-8. PubMed ID: 26634791
[TBL] [Abstract][Full Text] [Related]
13. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in nanomedicine preparative methods and their therapeutic potential for colorectal cancer: a critical review.
Jain A; Bhattacharya S
Front Oncol; 2023; 13():1211603. PubMed ID: 37427139
[TBL] [Abstract][Full Text] [Related]
15. Sulfonamide-Functionalized Polymeric Nanoparticles for Enhanced In Vivo Colorectal Cancer Therapy.
Guimarães PPG; Viana CTR; Pereira L; Gontijo SML; Campos PP; Andrade SP; Santos RAS; Sinisterra RD
Curr Drug Deliv; 2022; 19(6):676-685. PubMed ID: 34325632
[TBL] [Abstract][Full Text] [Related]
16. Nanomedicine for cancer diagnosis and therapy: advancement, success and structure-activity relationship.
Bhise K; Sau S; Alsaab H; Kashaw SK; Tekade RK; Iyer AK
Ther Deliv; 2017 Nov; 8(11):1003-1018. PubMed ID: 29061101
[TBL] [Abstract][Full Text] [Related]
17. Novel Nano-Therapeutic Approach Actively Targets Human Ovarian Cancer Stem Cells after Xenograft into Nude Mice.
Abou-ElNaga A; Mutawa G; El-Sherbiny IM; Abd-ElGhaffar H; Allam AA; Ajarem J; Mousa SA
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28417924
[TBL] [Abstract][Full Text] [Related]
18. Engineered nanoparticles for imaging and drug delivery in colorectal cancer.
Pavitra E; Dariya B; Srivani G; Kang SM; Alam A; Sudhir PR; Kamal MA; Raju GSR; Han YK; Lakkakula BVKS; Nagaraju GP; Huh YS
Semin Cancer Biol; 2021 Feb; 69():293-306. PubMed ID: 31260733
[TBL] [Abstract][Full Text] [Related]
19. The Advances in Chitosan-based Drug Delivery Systems for Colorectal Cancer: A Narrative Review.
Ali DS; Othman HO; Anwer ET
Curr Pharm Biotechnol; 2023; 24(12):1554-1559. PubMed ID: 36733239
[TBL] [Abstract][Full Text] [Related]
20. Epithelial cell adhesion molecule aptamer functionalized PLGA-lecithin-curcumin-PEG nanoparticles for targeted drug delivery to human colorectal adenocarcinoma cells.
Li L; Xiang D; Shigdar S; Yang W; Li Q; Lin J; Liu K; Duan W
Int J Nanomedicine; 2014; 9():1083-96. PubMed ID: 24591829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
